Michael Haffner, MD
Anatomic Pathology · Seattle, WANPI 1629455464
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,730 of the $13,651 with a category attached, or 78.6%. Pfizer accounts for 90.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $7,244 and has fallen 89.9% since, to $730 in 2025.
Across 12 payments — averaging $1137.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$12K
- AstraZeneca$923
- Sanofi$398
Across 3 payments — averaging $54,475 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$163K
What the payments were for
- Consulting fees$10,73079%
- Travel & lodging$2,60119%
- Food & beverage$3202%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $12,330 |
| AstraZeneca | 2 | $923 |
| Sanofi | 4 | $398 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TALZENNA$10,244
- NO PRODUCT DISCUSSED$287
How this compares
Too few anatomic pathology providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology in Seattle
- Monica DebacaSeattle$323K
- Behzad NajafianSeattle$82K
- Cheung ChhiengSeattle$2K
- Aashiyana KoreishiSeattle$322
- Paul EdmonsonSeattle$297
- Haodong XuSeattle$132
- Shreeram AkileshSeattle$127
- Rebeca AlvarezSeattle$90
- Jey-Hsin ChenSeattle$33
- Patrick CiminoSeattle$25
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.